Skip Navigation LinksHome > About the Journal

About the Journal

Anti-Cancer Drugs reports both clinical and experimental results related to anti-cancer drugs, and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation. An internationally refereed journal devoted to the fast publication of innovative investigations on therapeutic agents against cancer, Anti-Cancer Drugs aims to stimulate and report research on both toxic and non-toxic anti-cancer agents. Consequently, the scope on the journal will cover both conventional cytotoxic chemotherapy and hormonal or biological response modalities such as interleukins and immunotherapy.

Publication & Editorial Staff Contacts


Publication
Phil Daly
Phil.Daly@wolterskluwer.com

Production Editor
Kavi Ganeshananthan
Kavi.Ganeshananthan@wolterskluwer.com

Marketing
Danielle Beren
Danielle.Beren@wolterskluwer.com

Translation, Rights & Licensing
Silvia Serra
translationrights@wolterskluwer.com


International Advertising Representative
Avia Potashnik
Advertising & Sponsorship Manager, Europe
Phone: +44 203 197 6722
E-mail: avia.potashnik@wolterskluwer.com

LWW Business Offices
Citi Building, 41st Floor
25 Canada Square
Canary Wharf
London E14 5LQ, UK
Phone: +44(0)20 3197 6500
www.lww.com

Editor-in-Chief
Mels Sluyser, PhD
The Netherlands Cancer Institute-H4
Plesmanlaan 121
1066 CX Amsterdam
The Netherlands
Phone: +31 35 52 59 943
Fax: +31 20 51 22 029
m.sluyser@planet.nl